{
    "nct_id": "NCT04930991",
    "official_title": "A Phase 0 Study of High Dose Omeprazole in Patients With Pancreatic Cancer Planning to Undergo Surgical Therapy for Evaluating Changes of Biomarkers",
    "inclusion_criteria": "* Newly diagnosed exocrine pancreatic cancer with pathology confirmed as adenocarcinoma\n* Patient is a candidate for surgical resection of pancreatic cancer\n* â‰¥ 18 years old at the time of informed consent\n* ECOG Performance Status 0-2\n* Patients with or without neoadjuvant chemotherapy will be eligible\n* Ability to provide written informed consent and HIPAA authorization\n* Women of childbearing potential definition must have a negative pregnancy test within 14 days of registration. All women (regardless of sexual orientation, having undergone a tubal ligation, or remaining celibate by choice) are considered to have childbearing potential unless they meet one of the following criteria:\n* Prior hysterectomy or bilateral oophorectomy;\n* Has not had menses at any time in the preceding 24 consecutive months\n* Adequate organ function for surgical therapy\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 99 Years",
    "exclusion_criteria": "* Patients with pancreatic malignant tumor histologically confirmed as neuroendocrine or any other type of malignancies\n* Positive pregnancy test, pregnant, or breastfeeding\n* Known hypersensitivity to any component of the formulation or substituted benzimidazoles\n* Any other clinically significant laboratory abnormality that would compromise patient safety or the outcome of the study\n* Any clinically significant and/or uncontrolled cardiac-related abnormality that would compromise patient safety or the outcome of the study\n* Medical condition that might affect the absorption of study medications in the opinion of the investigator.",
    "miscellaneous_criteria": ""
}